SlideShare une entreprise Scribd logo
1  sur  18
Setting the Stage: Conducting Effective & Strategic Due Diligence Thomas Argentieri, Ph.D. ACI Conference Nov. 17, 2009 New York, NY
Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]
Introduction ,[object Object],[object Object],[object Object]
Pre-Deal Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],When satisfied with answers to above questions –  Decision to go to full due diligence
…  the objective …  of due diligence
Confirmatory Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object]
The Decision to Undertake Due Diligence ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Due Diligence Team Direct costs for 1 day diligence can easily  exceed $40,000-$50,000 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Partial Diligence
Due Diligence Team ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Due Diligence Team ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Typical DD Team Makeup (clinical asset) Preclinical Clinical Manufacturing
Team responsibilities: ,[object Object],[object Object],[object Object],[object Object],Due Diligence Team
Examples of Information Requested ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Examples of Information Requested
Product Under Development ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Critical Questions
Critical Questions Marketed Product ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Potential Problems
Other Sources of Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],√ √ √ √

Contenu connexe

Tendances

Framework for a business process management competency centre
Framework for a business process management competency centreFramework for a business process management competency centre
Framework for a business process management competency centreMartin Moore
 
FDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxFDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxGeorgeVardas2
 
Introduction to Business Process Analysis and Redesign
Introduction to Business Process Analysis and RedesignIntroduction to Business Process Analysis and Redesign
Introduction to Business Process Analysis and RedesignMarlon Dumas
 
Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018Bayer
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in indiaSomnath Surai
 
Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Andrew Pope
 
Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Zaki Sellam
 
Quality assurance documentation
Quality assurance documentationQuality assurance documentation
Quality assurance documentationImran Jamil
 
Project management
Project managementProject management
Project managementbinnz
 
Building a Business Case for Quality Management Transformation
Building a Business Case for Quality Management TransformationBuilding a Business Case for Quality Management Transformation
Building a Business Case for Quality Management TransformationVeeva Systems
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectBioMed Informatics
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer MilliporeSigma
 
Best in class pharma strategy wfv
Best in class pharma strategy wfvBest in class pharma strategy wfv
Best in class pharma strategy wfvJean-Michel Peny
 
Role of BA over project lifecycle
Role of BA over project lifecycleRole of BA over project lifecycle
Role of BA over project lifecycleSudeep Mathur
 

Tendances (20)

Framework for a business process management competency centre
Framework for a business process management competency centreFramework for a business process management competency centre
Framework for a business process management competency centre
 
S&OP Implementation Roadmap
S&OP Implementation RoadmapS&OP Implementation Roadmap
S&OP Implementation Roadmap
 
FDA Inspection Readiness.pptx
FDA Inspection Readiness.pptxFDA Inspection Readiness.pptx
FDA Inspection Readiness.pptx
 
PHARMA 4.0.pptx
PHARMA 4.0.pptxPHARMA 4.0.pptx
PHARMA 4.0.pptx
 
Introduction to Business Process Analysis and Redesign
Introduction to Business Process Analysis and RedesignIntroduction to Business Process Analysis and Redesign
Introduction to Business Process Analysis and Redesign
 
Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018Capital Markets Day in London - Investor Handout December 2018
Capital Markets Day in London - Investor Handout December 2018
 
S&OP Workshop
S&OP Workshop S&OP Workshop
S&OP Workshop
 
Pharmaceutical industry in india
Pharmaceutical industry in indiaPharmaceutical industry in india
Pharmaceutical industry in india
 
Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)Introduction to Discovery Partnerships with Academia (DPAc)
Introduction to Discovery Partnerships with Academia (DPAc)
 
Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model Ersnt & Young Pharma 3.0 Business Model
Ersnt & Young Pharma 3.0 Business Model
 
Quality assurance documentation
Quality assurance documentationQuality assurance documentation
Quality assurance documentation
 
The Medical Device Milestone Map
The Medical Device Milestone MapThe Medical Device Milestone Map
The Medical Device Milestone Map
 
Project management
Project managementProject management
Project management
 
Building a Business Case for Quality Management Transformation
Building a Business Case for Quality Management TransformationBuilding a Business Case for Quality Management Transformation
Building a Business Case for Quality Management Transformation
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical Industry
 
Pharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with ProjectPharmacovigilance Training in Oracle Argus Safety Database with Project
Pharmacovigilance Training in Oracle Argus Safety Database with Project
 
Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer Managing Process Scale-up and Tech Transfer 
Managing Process Scale-up and Tech Transfer 
 
Best in class pharma strategy wfv
Best in class pharma strategy wfvBest in class pharma strategy wfv
Best in class pharma strategy wfv
 
Role of BA over project lifecycle
Role of BA over project lifecycleRole of BA over project lifecycle
Role of BA over project lifecycle
 
Due diligence
Due diligenceDue diligence
Due diligence
 

En vedette

M&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsM&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsStephen Bainbridge
 
Sample due diligence checklist
Sample due diligence checklistSample due diligence checklist
Sample due diligence checklistLuis Espinosa
 
Successful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesSuccessful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesLawPlus Ltd.
 
Due Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouDue Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouNow Dentons
 
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson LLP
 
EY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY
 
Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014CMR WORLD TECH
 
Business Plans & Due Diligence
Business Plans & Due DiligenceBusiness Plans & Due Diligence
Business Plans & Due DiligenceEurofast
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsBarry Feldman
 
1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FVFran Viau
 
EY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeEY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeeyluxembourg
 
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverDue Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverPavan Kumar Vijay
 
Due Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsDue Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsFirmex
 
EY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY
 
Dealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessDealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessEY
 
Blockchain in capital markets and structured finance
Blockchain in capital markets and structured financeBlockchain in capital markets and structured finance
Blockchain in capital markets and structured financeEY
 
The impact of innovation on the future of IVD
The impact of innovation on the future of IVDThe impact of innovation on the future of IVD
The impact of innovation on the future of IVDEY
 
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Indonesia
 

En vedette (20)

M&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware DevelopmentsM&A Law: The Lawyer's Role; Recent Delaware Developments
M&A Law: The Lawyer's Role; Recent Delaware Developments
 
Sample due diligence checklist
Sample due diligence checklistSample due diligence checklist
Sample due diligence checklist
 
Successful Legal Due Diligence Strategies
Successful Legal Due Diligence StrategiesSuccessful Legal Due Diligence Strategies
Successful Legal Due Diligence Strategies
 
Due Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt YouDue Diligence - What You Don’t Find Out Will Hurt You
Due Diligence - What You Don’t Find Out Will Hurt You
 
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
Browne Jacobson - Education Law Conference 2016 - Workshop stream 1, Efficien...
 
EY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumersEY activities and solutions for insurers focusing on the emerging consumers
EY activities and solutions for insurers focusing on the emerging consumers
 
Project ppt
Project pptProject ppt
Project ppt
 
Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014Ey top-10-risks-in-telecommunications-2014
Ey top-10-risks-in-telecommunications-2014
 
Business Plans & Due Diligence
Business Plans & Due DiligenceBusiness Plans & Due Diligence
Business Plans & Due Diligence
 
The Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post FormatsThe Six Highest Performing B2B Blog Post Formats
The Six Highest Performing B2B Blog Post Formats
 
1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV1633946 - EY Services brochure 2015 FV
1633946 - EY Services brochure 2015 FV
 
EY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg officeEY Valuation & Business Modelling - Luxembourg office
EY Valuation & Business Modelling - Luxembourg office
 
Aldrich aimes
Aldrich aimesAldrich aimes
Aldrich aimes
 
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and TakeoverDue Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
Due Diligence for Merger & Acquisition, Corporate Restructuring and Takeover
 
Due Diligence Best Practices and Pitfalls
Due Diligence Best Practices and PitfallsDue Diligence Best Practices and Pitfalls
Due Diligence Best Practices and Pitfalls
 
EY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptxEY Analyse Gewinnwarnungen 2011-2016.pptx
EY Analyse Gewinnwarnungen 2011-2016.pptx
 
Dealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your businessDealing in a digital world - strategies to future-proof your business
Dealing in a digital world - strategies to future-proof your business
 
Blockchain in capital markets and structured finance
Blockchain in capital markets and structured financeBlockchain in capital markets and structured finance
Blockchain in capital markets and structured finance
 
The impact of innovation on the future of IVD
The impact of innovation on the future of IVDThe impact of innovation on the future of IVD
The impact of innovation on the future of IVD
 
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
EMLI Training-Legal Due Diligence for Acquisition Deal in Indonesian Mining P...
 

Similaire à Technical Due Diligence

Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Yavuz Silay
 
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Finalsecurbme
 
How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?Diaceutics Group
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureGRCTS
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialDavid Levin
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IProlifiq Software
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialGood Promotional Practices
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...Michael Swit
 
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCPACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCProlifiq Software
 
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small BiotechMary Syto
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory AffairsNamdeo Shinde
 
Drug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueDrug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueRobert Sturm
 
Research and Best Practices
Research and Best PracticesResearch and Best Practices
Research and Best PracticesMr.Yes!
 
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...Debi Prasad Dash
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical TrialsExL Pharma
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing ServiceVikram sathish Asokan
 

Similaire à Technical Due Diligence (20)

Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
Strategies for Conducting New Product Scientific Assessment - Yavuz SILAY - D...
 
SMI Talk
SMI TalkSMI Talk
SMI Talk
 
Speeding Towards Commercialization Gra 121808 Final
Speeding Towards Commercialization   Gra 121808 FinalSpeeding Towards Commercialization   Gra 121808 Final
Speeding Towards Commercialization Gra 121808 Final
 
How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?How much does it cost to launch and commercialize a companion diagnostic test?
How much does it cost to launch and commercialize a companion diagnostic test?
 
Product Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to ClosureProduct Complaints: Complaint Handling from Intake to Closure
Product Complaints: Complaint Handling from Intake to Closure
 
Regulatory Affairs
Regulatory AffairsRegulatory Affairs
Regulatory Affairs
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
 
Real-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part IReal-Life Compliance Solutions: Part I
Real-Life Compliance Solutions: Part I
 
Compliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational MaterialCompliant Dissemination of Promotional and Educational Material
Compliant Dissemination of Promotional and Educational Material
 
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...Regulatory, Quality & Clinical Due Diligence:  The Oft Overlooked Keys to Suc...
Regulatory, Quality & Clinical Due Diligence: The Oft Overlooked Keys to Suc...
 
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLCPACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
PACE: A Collaborative Process, Elsa Chi Abruzzo, President, ARAC, LLC
 
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
2015-11 Mary Syto CTS SoCal Challenges in Global Supply Mgmt in Small Biotech
 
Drug Regulatory Affairs
Drug Regulatory AffairsDrug Regulatory Affairs
Drug Regulatory Affairs
 
Drug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and RevenueDrug Development Life Cycle - Costs and Revenue
Drug Development Life Cycle - Costs and Revenue
 
Research and Best Practices
Research and Best PracticesResearch and Best Practices
Research and Best Practices
 
Biotechnology Consulting
Biotechnology ConsultingBiotechnology Consulting
Biotechnology Consulting
 
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...CASE STUDY ON  CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
CASE STUDY ON CORPORATE VENTURE CAPITAL FOR PHARMA INDUSTRY FOR "DELOITTE-MA...
 
Highlights from ExL Pharma's 4th Latin America Clinical Trials
Highlights from  ExL Pharma's 4th Latin America Clinical TrialsHighlights from  ExL Pharma's 4th Latin America Clinical Trials
Highlights from ExL Pharma's 4th Latin America Clinical Trials
 
Quality and Regulatory Affairs
Quality and Regulatory AffairsQuality and Regulatory Affairs
Quality and Regulatory Affairs
 
Pharma Regulatory & licensing Service
Pharma Regulatory & licensing ServicePharma Regulatory & licensing Service
Pharma Regulatory & licensing Service
 

Technical Due Diligence

  • 1. Setting the Stage: Conducting Effective & Strategic Due Diligence Thomas Argentieri, Ph.D. ACI Conference Nov. 17, 2009 New York, NY
  • 2.
  • 3.
  • 4.
  • 5. … the objective … of due diligence
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.